Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Overcome low yield & complex steps in flibanserin production. New 5-step route with 94.2% intermediate yield and 56.2% final yield. Reduce costs and supply chain risks.
Eliminate metal catalysts and inert gas requirements in quinoline synthesis. Our CDMO expertise ensures scalable, green production for antimalarial drugs and PDE4 inhibitors.
Solve aryl boronic acid synthesis challenges with thiosilane ligand: 80-86% yield, simplified purification, and industrial scalability for pharma intermediates.
Solve heavy metal contamination in 2-trifluoromethyl quinoline synthesis. Our metal-free, air-stable process cuts costs & ensures GMP compliance for drug development.
Solve low yield and purification challenges in arylboronic acid synthesis. Our CDMO expertise scales thiosilane ligand technology for 99% purity and cost efficiency.
Solve supply chain risks with metal-free, anhydrous-free 1,2,4-triazole synthesis. NINGBO INNO PHARMCHEM scales this patent-protected method for high-purity API intermediates.
Discover a 75-96% yield, room-temperature synthesis of 1,3,4-oxadiazole derivatives. Eliminate metal residues and toxic reagents for safer, cost-effective API manufacturing.
Solve supply chain risks with this metal-free, room-temperature pyrazole synthesis. No heavy catalysts, air-stable process, and high yields for API manufacturing.
Avoid heavy metal catalysts and anhydrous conditions in pyrido[1,2-a][1,3,5]-triazin-4-one synthesis. Reduce production costs and supply chain risks with this scalable, high-yield method.
Discover scalable chiral indolinopyrrole synthesis with 99% ee and 90%+ yield. Ideal for oncology drug development. Reduce costs and supply chain risks.
Discover scalable 2,6-dibromo-4-methylpyridine production with 68.5% yield and 99.5% purity. Eliminate column chromatography and reduce costs for pharmaceutical intermediates.
Discover a scalable Pd-catalyzed route for trifluoromethyl-chromone quinolines with 90%+ yields. Eliminate expensive pre-activation and harsh conditions. Reduce supply chain risks for your API synthesis.
Solve complex N-acyl indole synthesis challenges with high-yield, one-step palladium-catalyzed method. Reduce costs and scale-up risks for API production.
Discover how advanced cuprous bromide activation and palladium-catalyzed hydrogenation reduce solid waste by 90% while achieving 99.8% purity and 72% yield for AZD9291 production.
Solve axial chiral synthesis challenges with high-yield, mild-condition process. Reduce R&D costs and supply chain risks for asymmetric catalysts.
Eliminate CO gas handling risks and reduce production costs with this scalable multi-component synthesis for high-purity pharmaceutical intermediates.
Eliminate anhydrous/oxygen-free requirements in 5-trifluoromethyl triazole synthesis. Our CDMO expertise ensures high-yield, scalable production for drug intermediates.
Solve 4-aryl-NH-1,2,3-triazole synthesis challenges with this metal-free, one-pot method. Achieve 40-75% yields using stable aldehyde bisulfite adducts. Reduce production costs and supply chain risks for pharmaceutical intermediates.
Discover a cost-effective, metal-free synthesis method for 3,4,5-trisubstituted 1,2,4-triazoles. Eliminate anhydrous conditions and heavy metal catalysts to reduce production costs and supply chain risks.
High-yield, high-ee synthesis of non-natural amino acids with water as proton source. Reduce production costs and supply chain risks for API manufacturing.